Scale-up of the DMPA-SC in Nigeria: Why policy matters [PDF]
BMC Women's Health, 2022 Background Injectable contraceptives have contributed substantially to Nigeria's rise in modern family planning methods usage. They are one of the most commonly used and preferred means of contraception among women in the country.
Oluwaseun Akinyemi +5 more
doaj +5 more sources
Perspectives on DMPA-SC for self-injection among adolescents with unmet need for contraception in Malawi [PDF]
Frontiers in Global Women's Health, 2023 IntroductionMalawi has made progress in expanding access to modern contraceptive methods over the last decade, including the introduction of depot-medroxyprogesterone acetate subcutaneous (DMPA-SC) in 2018.
Gracious Ali +6 more
doaj +5 more sources
Feasibility and acceptability of DMPA-SC self-injection in Addis Ababa, Ethiopia: a mixed-methods study [PDF]
Reproductive HealthBackground Depot Medroxyprogesterone Acetate (DMPA) in a prefilled auto-disabled subcutaneous injectable contraceptive (Uniject™) can be administered by community health workers and clients.
Aderaw Anteneh +8 more
doaj +5 more sources
DMPA-SC stock: Cross-site trends by facility type [PDF]
Contraception: X, 2022 Objectives To measure trends in the supply of DMPA-SC in public and private health facilities and compare with other prominent modern methods. Study design We used repeated cross-sectional data from service-delivery-point surveys in six settings: Burkina
Funmilola Olaolorun +2 more
exaly +6 more sources
Health care provider and client experiences of counselling on depot medroxyprogesterone acetate subcutaneous (DMPA-SC) for self-injection in Malawi. [PDF]
PLOS Global Public Health, 2023 Since the introduction of subcutaneous depot medroxyprogesterone acetate (DMPA-SC) in 2018, Malawi has achieved national coverage of trained providers in the public sector and steady increases in uptake of DMPA-SC.
Chelsey Porter Erlank +6 more
doaj +6 more sources
Lessons from the scale-up of provider-administered and self-injection of DMPA-SC in Nigeria: a landscape assessment [PDF]
BMC Women's HealthBackground Nigeria is the seventh-most populous country in the world. Its high fertility rate and unmet need for family planning contribute to the increasing population size.
Adewole A. Adefalu +9 more
doaj +5 more sources
Setbacks in the road to self-injection: a descriptive study of provider and mystery client reports on the DMPA-SC care-seeking experience in Nigeria [PDF]
Frontiers in Global Women's HealthThis mixed-methods study describes perspectives from health providers and simulated clients on initiation and continuation of DMPA-SC for self-injection in Nigeria.
Madeline Griffith +9 more
doaj +5 more sources
Influence of Movement Restriction During the COVID-19 Pandemic on Uptake of DMPA-SC and Other Injectable Contraceptive Methods in Nigeria [PDF]
Open Access Journal of ContraceptionAdewole Adebola Adefalu,1 Olufunke Abimbola Bankole,2 Funmilayo Olabode,2 Mojuba Bimbo Afolabi,2 Miranda Atare Buba,2 Victor Dafe,2 Mishael Nnanna Kalu,2 Emily Watkins3 1JSI Research & Training Institute, Inc., Atlanta, GA, USA; 2JSI Research & ...
Adefalu AA +7 more
doaj +5 more sources
Predictors of DMPA-SC continuation among urban Nigerian women: the influence of counseling quality and side effects [PDF]
Contraception, 2018 Objectives In 2015, private healthcare providers in Nigeria introduced DMPA-SC (depot medroxyprogesterone acetate administered subcutaneously) into the method mix.
Yaning Shen +2 more
exaly +8 more sources
Cost-effectiveness of self-injected DMPA-SC compared with health-worker-injected DMPA-IM in Senegal [PDF]
Contraception: X, 2019 Objectives To evaluate the cost-effectiveness of self-injected subcutaneous depot medroxyprogesterone acetate (DMPA-SC) compared to health-worker-administered intramuscular DMPA (DMPA-IM) in Senegal and to assess how including practice or demonstration ...
Mercy Mvundura +2 more
exaly +6 more sources